Physician profile
David A Prager
NPI 1508817636
$2,862.65
in general payments reported to CMS, 2019-2025
16 companies · $436 in 2025
The $436 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $273 · 2021: $336 · 2022: $1,157 · 2023: $125 · 2024: $291 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $795 · Education: $56.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $794.71 |
| Education | $56.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $619.68 | 2021-2025 | Nucala |
| Medtronic, INC. | $420.40 | 2021-2025 | Nim Vital, Pteye Parathyroid Detection System, Propel |
| Genzyme Corporation | $331.30 | 2020-2025 | |
| Neurent Medical Limited | $209.23 | 2022-2025 | Neuromark Radiofrequency Console, Neuromark System |
| Optinose US, INC. | $204.46 | 2019-2025 | |
| Phathom Pharmaceuticals, INC. | $193.55 | 2024-2025 | Voquezna |
| Aerin Medical INC. | $190.31 | 2019-2024 | |
| Acclarent, INC | $188.90 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $152.23 | 2020-2024 | Libtayo |
| Intersect Ent, INC. | $125.39 | 2022 | |
| Sanofi-Aventis U.S. LLC | $56.95 | 2023 | |
| Alk-Abello, INC | $54.19 | 2019-2025 | Alternaria Tenuis, Histamine Positive, Timothy, Standardized |
| Stryker Corporation | $45.70 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $35.88 | 2022 | |
| Impel Pharmaceuticals INC. | $18.59 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15.89 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Prager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.